Categories: Tech

Columbus Weekly report on share buyback

Company announcement no. 39/2025

Transactions in the period 8 December 2025 to 12 December 2025
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company announcement no. 8/2025.

The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.

The following transactions were made under the share buyback programme in the period 8 December 2025 to 12 December 2025:

Number of shares bought Average purchase price (DKK) Transaction value (DKK)
Accumulated, last announcement 1,099,136 10.04 11,029,839.26
8 December 2025 7,000 9.72 68,019.70
9 December 2025 3,500 9.88 34,580.00
10 December 2025 7,000 9.72 68,040.00
11 December 2025 7,000 9.81 68,658.80
12 December 2025 7,000 9.70 67,919.60
Total, 8 December 2025 to 12 December 2025 31,500 9.75 307,218.10
Total accumulated under the programme 1,130,636 10.03 11,337,057.36

With the transactions stated above, Columbus A/S holds a total of 1,130,636 own shares, corresponding to 0.87% of the Company’s share capital.

For further information, please contact:
CFO, Brian Iversen, +45 70 20 50 00

GlobeNews Wire

Recent Posts

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 week ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 weeks ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

2 weeks ago

Secret Ingredient’s 2025: Redefining Hospitality through Story, Space and Strategy

NEW DELHI, Dec. 31, 2025 /PRNewswire/ -- Secret Ingredient, one of India's foremost food and…

4 weeks ago

GAC Receives Industry’s First Vehicle Data Security Management System Certificate

TIANJIN, China and GUANGZHOU, China, Dec. 31, 2025 /PRNewswire/ -- On December 24th, GAC received…

4 weeks ago